Combination therapy of antibodies against human csf-1r and uses thereof

摘要

Disclosed is the use of an antibody binding to human CSF-1R for the manufacture of a medicament for the treatment of cancer, wherein the treatment comprises administration of the anti-CSF-1R antibody in combination with an agonistic CD40 antibody.